trending Market Intelligence /marketintelligence/en/news-insights/trending/TNx2wf3S53o3RTXg_aLBoA2 content esgSubNav
In This List

NeoGenomics names chief scientific officer

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


NeoGenomics names chief scientific officer

NeoGenomics Inc. said it appointed Lawrence Weiss as the company's chief scientific officer.

Weiss has served as medical director and laboratory director for NeoGenomics Laboratories Inc. since joining NeoGenomics as part of the Clarient Diagnostic Services Inc. acquisition in 2015.

Previously, he acted as laboratory director for Clarient Diagnostic and chairman of the department of pathology and director of laboratories for City of Hope National Medical Center.

Fort Myers, Fla.-based NeoGenomics operates a network of cancer-focused genetic testing laboratories.